Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

Kathleen Costello discusses her new role as interim CEO of the CMSC. She has the support of Jeff Wilken, CMSC president, and Tina Trott, CMSC director.

Replacing June Halper: What's Next for CMSC

Articles

While effective in reducing amyloid plaques, donanemab carries a notable risk of amyloid-related imaging abnormalities (ARIA), underscoring the need for careful patient monitoring and risk management strategies.

Insights From the TRAILBLAZER-ALZ Program: Elevated ARIA Risk with Donanemab Highlights the Need for Vigilant Monitoring

Findings from a recently published large-scale analysis highlighted the high burden of cognitive impairment among veterans with both migraine and TBI. 

Veteran Analysis Reveals Significant Cognitive Symptoms Stemming From Migraine and Traumatic Brain Injury

The interim chief executive officer at the Consortium of Multiple Sclerosis Centers invites healthcare professionals to the Consortium’s annual meeting from May 28–31 in Phoenix, Arizona. [WATCH TIME: 2 minutes]

What to Expect From the 2025 CMSC Annual Meeting: Kathleen Costello, CRNP, MSCN

Interim chief executive officer of the Consortium of Multiple Sclerosis Centers.

The child neurologist and neuroimmunologist at Nationwide Children’s Hospital delved into the unique challenges and research objectives surrounding MOG antibody-associated disease. [WATCH TIME: 3 minutes]

Challenges and Research Priorities for Pediatric MOGAD: Kelsey Poisson, MD

, has been with the team since September 2022. Follow her on Twitter 

The professor of neurology at Northwestern University Feinberg School of Medicine discussed the NSD-ISS and its potential to refine PD diagnosis and clinical trial selection through biomarker-driven staging.

NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

ACTRIMS 2025

ISC 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

1rem

View

Cure SMA:  Evaluation of SMA in the Era of Telehealth

Cure SMA

SAP Partners

The NeurologyLive Cure Connections series, “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth,” put on in partnership with Cure SMA, features Diana Castro, MD, and Garey H. Noritz, MD, who offer tips and demonstrations for screening and diagnosing SMA via telehealth. Additionally, resources provided by Cure SMA are outlined for families and clinicians who suspect SMA or have a patient diagnosed with SMA.

Diana Castro, MD walks us through a pediatric neurological exam and notes examination findings that may be identified in an infant with Spinal Muscular Atrophy (SMA).

Pediatric Neurological Exam to Identify SMA

Garey H. Noritz, MD, walks us through a virtual pediatric neurological exam and notes examination findings that may be identified in an infant with Spinal Muscular Atrophy (SMA).

Virtual Exam Findings in an Infant Affected by Spinal Muscular Atrophy 

Early recognition and referral of a patient with suspected spinal muscular atrophy (SMA) to a neurologist.

Referral of SMA to a Neurologist

Diana Castro, M.D., discusses newborn screening for spinal muscular atrophy (SMA) and suggests how to care for patients after the results are received.  

Newborn Screening for SMA

The signs and symptoms leading a pediatrician to a diagnosis of spinal muscular atrophy (SMA) are discussed.

Signs and Symptoms of SMA

Diana Castro, M.D., stresses the value of the initial in-person neurology visit for evaluation of spinal muscular atrophy (SMA) to ensure a correct diagnosis. The next step in the process would be genetic testing.

Evaluation of Suspected SMA via In-Person and Remote Exam

Discussing the diagnosis of spinal muscular atrophy (SMA) with the family and lining up appointments with the multidisciplinary team to help care for the patient.

Discussing the Diagnosis of SMA With the Family

Several spinal muscular atrophy (SMA) resources are suggested to help physicians and families, including Cure SMA and standard of care guidelines.

SMA Resources for Physicians and Families

Resources are discussed, including the Child Neurology Foundation’s telehealth tip sheet, to help families navigate telehealth.

Telehealth During COVID-19

Experts remind families of the importance of follow-up visits with the multidisciplinary team during COVID-19.

Importance of Follow-Up Visits for SMA Amid COVID-19

Closing thoughts on advice to community neurologists treating spinal muscular atrophy (SMA).

Advice to Community Neurologists Treating SMA

SAP Partner

Clinical

 video series brings together expert clinicians and patients with neurologic diseases and disorders to discuss the landscapes of care, management, and treatment from both perspectives.

Pediatric Neurological Exam to Identify SMA

EP: 1.Pediatric Neurological Exam to Identify SMA

EP: 2.Virtual Exam Findings in an Infant Affected by Spinal Muscular Atrophy

EP: 3.Referral of SMA to a Neurologist

EP: 4.Newborn Screening for SMA

EP: 5.Signs and Symptoms of SMA

EP: 6.Evaluation of Suspected SMA via In-Person and Remote Exam

EP: 7.Discussing the Diagnosis of SMA With the Family

EP: 8.SMA Resources for Physicians and Families

EP: 9.Telehealth During COVID-19

EP: 10.Importance of Follow-Up Visits for SMA Amid COVID-19

EP: 11.Advice to Community Neurologists Treating SMA